Status: Recruiting
Exploratory Single-arm, Single-center Adjuvant Treatment of Stage IIIB-IIIC Gastric Cancer With Combination of Palizumab and SOX Regimen
it is an an Exploratory Single-Arm, Single-Center Study of Pembrolizumab in Combination with SOX Regimen for Adjuvant Treatment of Stage IIIB-IIIC Gastric Cancer
Participants needed: 20
Trial details
Phase: Phase 2Age: 18-75Biological sex: AllType: InterventionalSponsor: Shanghai Minimally Invasive Surgery CenterUpdated: Mar 7, 2024Locations: 1
Eligibility criteria
Consistent with high-frequency microsatellite instability MSI-H [+6]
Patients with severe hypertension and poor drug control; [+10]